SCHEMBL473578

SCHEMBL473578

NCCc1ccc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 7/20 0.56
TAAR1 Q96RJ0 4/20 0.56
CYP3A4 P08684 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 2/20 0.52
HTR2A P28223 1/20 0.50
TRPM8 Q7Z2W7 1/20 0.50
MAOB P27338 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
MAOA P21397 1/20 0.45
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29787088 1.00 IDO1 (0.56) IDO1TAAR1CYP3A4CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL3591333 0.98 IDO1 (0.57) IDO1TAAR1CYP3A4CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL28650595 0.98 IDO1 (0.57) IDO1TAAR1CYP3A4CYP1A2CYP2C9
SCHEMBL895036 0.87 IDO1 (0.52) IDO1TAAR1CYP3A4CYP1A2CYP2C9
SCHEMBL11621292 0.85 IDO1 (0.65) IDO1CYP3A4CYP1A2CYP2C9MAPK1
SCHEMBL25143270 0.85 CYP1A2 (0.51) IDO1CYP3A4CYP1A2CYP2C9MAPK1
Hydrochloric Acid SCHEMBL14829950 0.85 IDO1 (0.53) IDO1CYP3A4CYP1A2CYP2C9MAPK1
Trifluoroacetic Acid SCHEMBL6435993 0.83 IDO1 (0.50) IDO1
SCHEMBL1570136 0.82 TAAR1 (0.56) IDO1TAAR1HTR2ATRPM8MAOB
SCHEMBL6676181 0.82 TAAR1 (0.56) TAAR1CYP3A4MAOBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145472-A1 METHOD FOR GENERATING CARBON DIOXIDE KOBE GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-05-08 US claimed
EP-4480568-A1 METHOD FOR GENERATING CARBON DIOXIDE Kobe Gakuin Educational Foundation (JP) 2024-12-25 EP claimed
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 US claimed
EP-4313943-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-02-07 EP claimed
CN-117082953-A Optoelectronic device and method for producing the same 天合光能股份有限公司 2023-11-17 CN claimed
WO-2023153506-A1 METHOD FOR GENERATING CARBON DIOXIDE 学校法人神戸学院 2023-08-17 WO claimed
WO-2022200208-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2022-09-29 WO claimed
CN-113292493-A Preparation method of 5, 7-dichloro-1, 2,3, 4-tetrahydroisoquinoline 上海立科化学科技有限公司 2021-08-24 CN claimed
EP-1773768-B1 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2018-08-22 EP claimed
US-9409917-B2 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2016-08-09 US claimed
EP-1441750-A2 LINEAR AND CYCLIC MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES Palatin Technologies, Inc. (US) 2004-08-04 EP claimed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP claimed
WO-2003076403-A1 1,2-DISUBSTITUDED-6-OXO-3-PHENYL-PIPERIDINE-3-CARBOXAMIDES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2003-09-18 WO claimed
US-20030171588-A1 1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof LION BIOSCIENCE AG (DE) 2003-09-11 US claimed
WO-2003006620-A2 LINEAR AND CYCLIC MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES PALATIN TECHNOLOGIES, INC. (US) 2003-01-23 WO claimed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO claimed
EP-1126833-A2 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2001-08-29 EP claimed
WO-2000025768-A1 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES, INC. (US) 2000-05-11 WO claimed
EP-0906267-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 1-PHENYLETHYLAMINES BAYER AG (DE) 1999-04-07 EP claimed
WO-1997049665-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 1-PHENYLETHYLAMINES BAYER AKTIENGESELLSCHAFT (DE) 1997-12-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171588-A1 1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof BRD4, BICRA, HDAC6 IDO1 1498/4885TAAR1 1487/4885CYP3A4 3801/4885
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES HPD, DDT, PPOX IDO1 274/4885TAAR1 3744/4885CYP3A4 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.